Schizophrenia related to Dopamine deficiency

By SWA

Schizophrenia is primarily associated with an imbalance of neurotransmitters in the brain, including dopamine, but the relationship is more complex than a simple deficiency. The dopamine hypothesis of schizophrenia, one of the leading theories, suggests that symptoms of schizophrenia, particularly the positive symptoms like hallucinations and delusions, are partly due to an overactivity of dopamine transmission in certain areas of the brain.

However, it's not as straightforward as an overall excess or deficiency of dopamine. The theory posits that there may be an overactivity of dopamine D2 receptors in the mesolimbic pathway, which could contribute to the positive symptoms of schizophrenia. Conversely, negative symptoms (such as apathy, lack of emotion, and poor social functioning) and cognitive symptoms may be related to dopamine dysfunction in other brain pathways, such as the mesocortical pathway, where there may be a relative deficiency.

Moreover, recent research suggests that the dopamine hypothesis is an oversimplification. Schizophrenia is likely the result of a complex interplay between various neurotransmitters beyond dopamine, including glutamate, serotonin, and GABA, as well as environmental factors and genetic predisposition.

In summary, while dopamine plays a crucial role in the pathophysiology of schizophrenia, it's not solely about deficiency; it's more about the dysregulation of dopamine systems in different parts of the brain. This nuanced understanding has implications for the treatment of schizophrenia, where dopamine antagonists (antipsychotics) are used to reduce dopamine activity and alleviate symptoms, but with varying degrees of effectiveness and side effects.

Dopamine hypothesis of schizophrenia:
https://en.wikipedia.org/wiki/Dopamine_hypothesis_of_schizophrenia

Dopamine in schizophrenia: a review and reconceptualization:
https://pubmed.ncbi.nlm.nih.gov/1681750/

 

 

Comments

Post a Comment

Popular posts from this blog

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By SWA
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more